{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-22-011498","form_type":"8-K","ticker":"PALI","cik":"0001357459","company_name":"PALISADE BIO, INC.","filed_at":"2022-06-10T23:59:59+00:00","discovered_at":"2026-05-14T18:04:00.354508+00:00","generated_at":"2026-06-25T02:40:34.550577+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Palisade Bio shareholders elect two Class II directors and ratify auditor at 2022 annual meeting","bullets":["Election of Donald Williams and Robert J. Trenschel as Class II directors to serve until 2025.","Ratification of BDO USA as independent auditor for FY2022 with 8,731,767 votes for.","Advisory approval of named executive officer compensation passed with 3,765,654 votes for.","10,123,515 shares present (55.52% of outstanding); quorum achieved."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-22-011498","json":"https://secwatch.observer/filing/0000950170-22-011498.json","markdown":"https://secwatch.observer/filing/0000950170-22-011498.md","text":"https://secwatch.observer/filing/0000950170-22-011498.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1357459/000095017022011498/0000950170-22-011498-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1357459/000095017022011498/pali-20220609.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T02:40:34.550577+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}